SELARL PHARMACIE NOTRE DAME is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MURET (31600),
this company of category PME
shows in 2023 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE NOTRE DAME (SIREN 799068788)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 817 074 €
1 635 886 €
N/C
N/C
N/C
N/C
N/C
1 304 173 €
Net income
31 979 €
48 385 €
61 364 €
84 722 €
22 523 €
58 327 €
44 816 €
55 392 €
32 434 €
EBITDA
N/C
79 350 €
102 513 €
N/C
N/C
N/C
N/C
N/C
79 408 €
Net margin
N/C
2.7%
3.8%
N/C
N/C
N/C
N/C
N/C
2.5%
Revenue and income statement
In 2024, SELARL PHARMACIE NOTRE DAME generates positive net income of 32 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 32 k€ -> 32 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
31 979 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 73%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
72.563%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.197%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
705.034
451.436
342.564
247.168
204.425
140.566
108.682
86.285
72.563
Financial autonomy
10.55
14.854
19.352
24.638
26.329
34.006
39.871
40.923
46.197
Repayment capacity
19.567
None
None
None
None
None
6.479
7.164
None
Cash flow / Revenue
3.379%
None%
None%
None%
None%
None%
4.609%
3.287%
None%
Sector positioning
Debt ratio
72.562024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of SELARL PHARMACIE NOTRE DAME (72.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.2%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+5 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE NOTRE DAME (46.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
7.16 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of SELARL PHARMACIE NOTRE DAME (7.16) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 126.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
109.419
114.298
129.534
133.383
108.352
122.899
134.687
122.071
126.795
Interest coverage
22.149
None
None
None
None
None
6.494
6.364
None
Sector positioning
Liquidity ratio
126.82024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of SELARL PHARMACIE NOTRE DAME (126.80) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
6.36x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of SELARL PHARMACIE NOTRE DAME (6.4x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE NOTRE DAME
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
140 668 €
0 €
0 €
0 €
0 €
0 €
172 553 €
156 741 €
0 €
Inventory turnover (days)
36
0
0
0
0
0
30
28
0
Customer payment term (days)
5
0
0
0
0
0
5
6
0
Supplier payment term (days)
47
0
0
0
0
0
44
61
0
Positioning of SELARL PHARMACIE NOTRE DAME in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE NOTRE DAME is estimated at
446 450 €
(range 310 901€ - 667 915€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
310k€446k€667k€
446 450 €Range: 310 901€ - 667 915€
NAF 5 année 2024
Valuation method used
Net Income Multiple
31 979 €
×
14.0x
=446 450 €
Range: 310 901€ - 667 915€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE NOTRE DAME with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE NOTRE DAME
What is the revenue of SELARL PHARMACIE NOTRE DAME ?
The revenue of SELARL PHARMACIE NOTRE DAME in 2023 is 1.8 M€.
Is SELARL PHARMACIE NOTRE DAME profitable?
Yes, SELARL PHARMACIE NOTRE DAME generated a net profit of 32 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE NOTRE DAME ?
The headquarters of SELARL PHARMACIE NOTRE DAME is located in MURET (31600), in the department Haute-Garonne.
Where to find the tax return of SELARL PHARMACIE NOTRE DAME ?
The tax return of SELARL PHARMACIE NOTRE DAME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE NOTRE DAME operate?
SELARL PHARMACIE NOTRE DAME operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart